FDA Unveils Plan To Speed Up Approval, Marketing Of Biosimilars.

The Wall Street Journal (7/18, Burton, Subscription Publication) reports that, as part of the Trump Administration’s efforts to lower drug prices, the FDA is releasing a plan which will make it easier to obtain approval for, and market, biosimilars. FDA...